| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | A |
| 8. Outlier Analysis | C |
| 9. Normality | A |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | C |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | C8,10,12 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Urine |
| Measurand | C-terminal cross-linked telopeptide of type I collagen (CTX) |
| Unit | ug / mmol creatinine |
| Overall Analytical Principle Method | Immunoassay; ELISA |
| Number of Subjects | 15 |
| Number of Subjects included in BV estimation | 15 |
| Ethinicity | Unknown |
| Age Mean / Median | 40.0 |
| Age Min | 28.0 |
| Age Max | 49.0 |
| Age SD | 6.2 |
| Number of Males | |
| Number of Females | 15 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 1 |
| Study Duration Units | Year |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 3 |
| Interval Units | Month |
| Sampling Times | Start Time:
8:00
End Time: 10:00 |
| Number of Samples | 4 |
| Average Number of Samples Used for BV Estimation | 4.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 25.6 |
| Calculated Confidence Intervals of CVi | Lower: 21.09, Upper: 32.42 |
| Estimates of CVg | 36.3 |
| Calculated Confidence Intervals of CVg | Lower: 25.18, Upper: 58.22 |
| Analytical CV | 6.2 |
| Calculated Confidence Intervals of Analytical CV | Lower: 5.26, Upper: 7.55 |
| Measurand Mean | 128.1 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |